Koyfin Home > Directory > Health Care > Antares Pharma > Preferred Equity

Antares Pharma Preferred Equity Chart (ATRS)

Antares Pharma annual/quarterly Preferred Equity from 2001 to 2005.
  • Antares Pharma Preferred Equity for the quarter ending June 06, 2005 was $0m a -93.75% decrease of 0m year over year
  • Antares Pharma Preferred Equity for the last 12 months ending June 06, 2005 was $0m a -93.75% decrease of 0m year over year
  • Antares Pharma Annual Preferred Equity for 2004 was $0m a -276.65% decrease of 0m from 2003
  • Antares Pharma Annual Preferred Equity for 2003 was $0m a 99.43% increase of 0m from 2002
  • Antares Pharma Annual Preferred Equity for 2002 was $0m a 7.14% increase of 0m from 2001
Other Balance Sheet Metrics:
  • Antares Pharma Total Assets for the quarter ending December 12, 2018 was $88m a 19.07% increase of 17m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Equity for the quarter ending December 12, 2018 was $39m a 27.57% increase of 11m year over year
View Chart On Koyfin

Quarterly ATRS Preferred Equity Data

06/2005$0m
03/2005$0m
12/2004$0m
09/2004$0m
06/2004$0m
03/2004$0m
12/2003$0m
09/2003$0m
06/2003$0m
03/2003$0m

Annual ATRS Preferred Equity Data

2004$0m
2003$0m
2002$0m
2001$0m